Lv3
236 积分 2023-09-27 加入
Lynch Syndrome Genetics and Clinical Implications
12天前
已完结
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
19天前
已完结
The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer
19天前
已完结
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
19天前
已完结
RB1 genetic alterations in estrogen receptor-positive breast carcinomas: Correlation with neuroendocrine differentiation
26天前
已完结
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
29天前
已完结
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial
1个月前
已完结
Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer
1个月前
已完结
Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA
1个月前
已完结
Identifying Circulating Tumor DNA Mutations Associated with Neoadjuvant Chemotherapy Efficacy in Local Advanced Breast Cancer
1个月前
已完结
皖公网安备34019202002308
